ABLE Financial Group’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
ABLE Financial Group's RMD Position: Q3 2026 in Review
ABLE Financial Group increased its ResMed (RMD) stake by 6.9% in Q3 2026, buying an estimated $26.2K and bringing the position to 1,850 shares worth $409K. The position accounts for 0.06% of the portfolio, ranked #160.
ABLE Financial Group first reported a position in RMD in Q2 2023 and has held it in 14 quarters since. The position peaked at $627K in Q3 2024. 167 funds tracked by Wall St. Rank hold RMD as of Q3 2026.
- ABLE Financial Group held 1,850 shares of ResMed worth $409K as of Q3 2026.
- ABLE Financial Group bought 120 ResMed shares in Q3 2026, an estimated $26.2K.
- ResMed made up 0.06% of ABLE Financial Group's portfolio in Q3 2026, its #160 holding.
- ABLE Financial Group first reported a position in ResMed in Q2 2023 and has held it in 14 quarters since.
- ABLE Financial Group's ResMed position peaked at $627K in Q3 2024.
- 167 funds tracked by Wall St. Rank held ResMed as of Q3 2026.
Based on ABLE Financial Group's 13F filing for Q3 2026, filed 14 Oct 2026.